Shearman & Sterling LLP represented Quest Diagnostics Incorporated in a shelf takedown of $800 million aggregate principal amount of its 2.950 percent senior notes due 2030. J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Wells Fargo Securities, LLC, Goldman Sachs & Co. LLC and Mizuho Securities USA LLC acted as joint book-running managers for the offering. 

Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.

The Team